Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Challenge Fund - Etgar is a pioneering Israeli venture capital firm established in 1995 as part of the Yozma program to foster the nation's high-tech and life sciences sectors. The fund specialized in early-stage and seed investments in innovative Israeli startups, providing both capital and strategic mentorship. Its portfolio has included significant successes in the healthcare space, such as Given Imaging, Compugen, and V-Wave. Managed by experienced professionals including Joseph Loevy and Dr. Shmuel Cabilly, the fund played a foundational role in the development of the Israeli biotech ecosystem. While the fund is no longer actively making new investments, it remains a landmark entity in the history of Israeli venture capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Etgar Challenge Fund.